Conisus provides specialized medical communication services to the oncology pharmaceutical and biotechnology industry. The company creates innovative promotional marketing and education solutions for a diverse group of biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies.
Recapitalized into ³Ô¹Ï±¬ÁÏ Capital II-A LP on November 9, 2017.
Details.
Status:
Realized
Year Invested:
2010
Website:
www.conisus.com
Category:
Healthcare
Fund:
Fund II, Fund II -A